in Ann Oncol during April 2008 -- updated monthly
Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.
| 6. | O. Mir, P. Berveiller, S. Ropert, F. Goffinet, G. Pons, J.-M. Treluyer, F. Goldwasser | ||
| Emerging therapeutic options for breast cancer chemotherapy during pregnancy | |||
|---|---|---|---|
|
Ann Oncol Apr 01, 2008; 19: 607-613.
(In "Reviews") |
|||
| 7. | P. Boyle, J. Ferlay | ||
| Cancer incidence and mortality in Europe, 2004 | |||
|
Ann Oncol Mar 01, 2005; 16: 481-488.
(In "Epidemiology") |
|||
| 8. | N. Perry, M. Broeders, C. de Wolf, S. Törnberg, R. Holland, L. von Karsa | ||
| European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary document | |||
|
Ann Oncol Apr 01, 2008; 19: 614-622.
(In "Reviews") |
|||
| 9. | E. Weidmann, S.-Z. Kim, A. Rost, H. Schuppert, G. Seipelt, D. Hoelzer, P. S. Mitrou | ||
| Bendamustine is effective in relapsed or refractory aggressive non-Hodgkins lymphoma | |||
|
Ann Oncol Aug 01, 2002; 13: 1285-1289.
(In "Hematologic malignancies") |
|||
| 10. | J. Tol, M. Koopman, C. J. Rodenburg, A. Cats, G. J. Creemers, J. G. Schrama, F. L. G. Erdkamp, A. H. Vos, L. Mol, N. F. Antonini, C. J. A. Punt | ||
| A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity | |||
|
Ann Oncol Apr 01, 2008; 19: 734-738.
(In "Gastrointestinal tumors") |
|||
| [Previous 5 Articles] [Next 5 Articles] | |||
= from the current issue
Last Updated: 05/05/2008 07:44:05